CPT 0932T · Outpatient
$313
Hospital outpatient technical component
National average · APC 5743 · CY2026
Reimbursement
Coding and reimbursement overview
Coding and reimbursement overview
for Precision Cardiac Amyloid
An educational overview of the codes that apply to Precision Cardiac Amyloid: CPT Category III code 0932T for outpatient studies, and a Medicare inpatient New Technology Add-on Payment (NTAP) effective October 1, 2026. Coverage and payment are determined by the applicable payer.
XEZZXLC · Inpatient
Up to $2,275
Medicare New Technology Add-on Payment
Per eligible Medicare stay · on top of the MS-DRG · effective 10/01/2026
Site of service
Two settings. Two codes.
Most echocardiograms are performed in the outpatient setting, and most reimbursement conversations stop there. For Precision Cardiac Amyloid, coding pathways exist in both the outpatient and inpatient settings.
Outpatient and office. CPT 0932T describes the augmentative analysis of an echocardiogram demonstrating preserved ejection fraction. Under the hospital outpatient prospective payment system (OPPS) it currently carries status indicator S and is assigned to APC 5743, so it is not packaged into the echocardiogram CPT. Similar to strain, 3D, or contrast, it is a separate additional code.
Inpatient. A Medicare New Technology Add-on Payment (ICD-10-PCS XEZZXLC) applies to eligible Medicare inpatient stays, up to $2,275 on top of the MS-DRG, effective October 1, 2026.
Using InVision Precision Cardiac Amyloid does not by itself establish that the reporting, documentation, medical-necessity, coding, or coverage requirements for any code or payment have been met; those requirements must be satisfied and verified independently for each claim.
New: how the NTAP is calculated, worked through three example discharges.
Medicare fee-for-service. Medicare Advantage and commercial inpatient payment follow your contracts with those plans.
| Setting | Report | Rate | Status |
|---|---|---|---|
| Hospital outpatientTechnical component | CPT 0932TAPC 5743 | $313 | Effective Jan 1, 2025 |
| Physician professionalAny place of service | CPT 0932T-26Modifier 26 | — | Effective Jan 1, 2025 |
| OfficeAny place of service | CPT 0932TGlobal | — | Effective Jan 1, 2025 |
| Hospital inpatientNew Technology Add-on Payment | XEZZXLCICD-10-PCS | Up to $2,275Per eligible Medicare stay | Effective 10/01/2026 |
Coding & reimbursement education
Request Coding & Reimbursement Education
Have questions about CPT 0932T or the Medicare NTAP? Request our general, product-specific coding and reimbursement education, and our team will follow up to answer your questions. We provide general educational information only — we do not prepare, review, or submit claims, reconcile billing, or provide revenue-cycle services.
You can also email your coding or reimbursement questions to reimbursement@invisionmedtech.com.
We reply within one business day.
FAQ
Reimbursement FAQ
Is InVision Precision Cardiac Amyloid reimbursed by Medicare?
Coding pathways exist in both the outpatient and inpatient settings. In the hospital outpatient setting, CPT Category III code 0932T is reported; for eligible Medicare inpatient stays, a New Technology Add-on Payment (ICD-10-PCS XEZZXLC) of up to $2,275 applies on top of the MS-DRG, effective 1 October 2026. Coverage and payment are determined by the applicable payer.
What is the Medicare New Technology Add-on Payment (NTAP)?
It is an additional Medicare payment of up to $2,275 per eligible Medicare inpatient stay, paid on top of the MS-DRG and effective 1 October 2026 (ICD-10-PCS XEZZXLC). It applies to Medicare fee-for-service; Medicare Advantage and commercial inpatient payment follow your contracts with those plans.
How the NTAP is calculated, worked through three example discharges →
What is CPT code 0932T?
CPT Category III code 0932T describes the augmentative analysis of an echocardiogram demonstrating preserved ejection fraction, effective 1 January 2025. Under the hospital outpatient prospective payment system it currently carries status indicator S and is assigned to APC 5743 (a national average of about $313 for the technical component), so it is not packaged into the echocardiogram CPT. Similar to strain, 3D, or contrast, it is a separate additional code.
Who decides whether a claim is covered and paid?
The provider. Using InVision Precision Cardiac Amyloid does not by itself establish that the reporting, documentation, medical-necessity, coding, or coverage requirements for any code or payment have been met; those requirements must be satisfied and verified independently for each claim with the applicable payer.
Is this coding and reimbursement advice?
No. This is general educational information only. It is not legal advice or advice about how to code, complete, or submit any particular claim, and it is not a quote or a promise that any payer will pay any amount. CMS payment rates and coding are updated at least annually; verify current requirements with the applicable payer before filing.
Educational information only
The information on this page is general reimbursement information only. It is not legal advice, nor advice about how to code, complete, or submit any particular claim, and it is not a quote or a promise that any payer will pay any amount. The rates shown are national Medicare reference amounts. Coverage, coding, and payment are the provider's responsibility and depend on the patient's plan, site of service, documentation, and medical necessity; it is the provider's responsibility to determine medical necessity and to select and submit the appropriate codes, charges, modifiers, and bills for the services rendered. Payers and their local branches may have distinct coding, coverage, and reimbursement requirements, and CMS payment rates and coding are updated at least annually. Before filing any claim, verify current requirements and policies with the applicable payer.
Current as of 08/03/2026